Biodesix, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Biodesix, Inc. now
Current reporting with the operating signal separated from the noise.
Stempoint Capital LP Acquires New Holdings in Biodesix, Inc. $BDSX
The story matters when it changes Biodesix, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Biodesix, Inc.: Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
The story matters when it changes Biodesix, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Biodesix, Inc. (BDSX) Q3 2025 Earnings Call Transcript
Investors are testing whether Biodesix, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Biodesix, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
The story matters when it changes Biodesix, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Biodesix, Inc. Reports Preliminary Financial Results for Fourth Quarter and Fiscal Year 2024 with Significant Revenue Growth
Investors are testing whether Biodesix, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors
The story matters when it changes Biodesix, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest BDSX filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Biodesix, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →